State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Oncogene. 2022 Jun;41(23):3197-3209. doi: 10.1038/s41388-022-02334-6. Epub 2022 Apr 30.
Thermal ablation is a main curative therapy for early-stage hepatocellular carcinoma (HCC). However, insufficient ablation has been shown to promote HCC progression. E3 ligases have been approved to play important roles in malignant tumors. Whether E3 ligases are involved in HCC progression caused by insufficient ablation remains unclear. Herein, using RNA-sequencing coupled with an in vitro loss-of-function screen, we found that the E3 ligase Neuronal Precursor cell-expressed Developmentally Downregulated 4 (Nedd4) was upregulated in HCC insufficient ablation tissues and promoted HCC cells migration. The upregulation of Nedd4 was induced by METTL14-mediated N-methyladenosine modification after sublethal heat treatment. Knockdown of Nedd4 inhibited HCC metastasis and growth in vitro and in vivo. Mechanistically, Nedd4 enhanced TGF-β signal transduction mediated tumor progression by directly binding to TGF-β type I receptor (TGFBR1) and forming K27-linked ubiquitin at Lysine 391. Additionally, the adverse effect on HCC of sublethal heat treatment was mediated by Nedd4. Clinically, high Nedd4 expression was positively correlated with aggressive tumor phenotypes and poor prognosis in HCC patients. Patient-derived xenograft (PDX) model confirmed this conclusion. Collectively, this study demonstrated that Nedd4 induced by insufficient ablation plays a crucial role in promoting HCC progression and provides a novel therapeutic target for HCC.
热消融是治疗早期肝细胞癌(HCC)的主要治疗方法。然而,已经表明消融不足会促进 HCC 的进展。E3 连接酶已被批准在恶性肿瘤中发挥重要作用。E3 连接酶是否参与消融不足引起的 HCC 进展尚不清楚。在此,我们通过 RNA 测序结合体外功能丧失筛选,发现 E3 连接酶神经元前体细胞表达发育下调 4 型(Nedd4)在 HCC 消融不足组织中上调,并促进 HCC 细胞迁移。在亚致死热处理后,METTL14 介导的 N6-甲基腺苷修饰诱导了 Nedd4 的上调。Nedd4 的敲低抑制了 HCC 在体外和体内的转移和生长。在机制上,Nedd4 通过直接结合 TGF-β 型 I 受体(TGFBR1)并在赖氨酸 391 处形成 K27 连接的泛素,增强 TGF-β 信号转导介导的肿瘤进展。此外,亚致死热处理对 HCC 的不利影响是由 Nedd4 介导的。临床上,Nedd4 的高表达与 HCC 患者侵袭性肿瘤表型和不良预后呈正相关。患者来源的异种移植(PDX)模型证实了这一结论。总之,这项研究表明,消融不足诱导的 Nedd4 在促进 HCC 进展中起着关键作用,并为 HCC 提供了一个新的治疗靶点。